ImmunoGen, Inc.

NORTHERN TRUST CORP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

2,328,671

Value ($000)

69,045

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	69,045	0.0%	2,328,671	12/31/2023
2023 Q3	11/13/2023	37,626	0.0%	2,370,864	9/30/2023
2023 Q2	8/11/2023	45,213	0.0%	2,396,046	6/30/2023
2023 Q1	5/15/2023	8,232	0.0%	2,143,821	3/31/2023
2022 Q4	2/13/2023	10,657	0.0%	2,148,536	12/31/2022
2022 Q3	11/14/2022	10,167	0.0%	2,126,854	9/30/2022
2022 Q2	8/12/2022	9,648	0.0%	2,144,130	6/30/2022
2022 Q1	5/13/2022	10,463	0.0%	2,198,238	3/31/2022
2021 Q4	2/8/2022	15,801	0.0%	2,129,508	12/31/2021
2021 Q3	11/15/2021	11,954	0.0%	2,108,404	9/30/2021
2021 Q2	8/13/2021	14,052	0.0%	2,132,366	6/30/2021
2021 Q1	5/12/2021	16,984	0.0%	2,096,792	3/31/2021
2020 Q4	2/11/2021	13,663	0.0%	2,118,275	12/31/2020
2020 Q3	11/16/2020	7,412	0.0%	2,059,025	9/30/2020
2020 Q2	8/14/2020	9,896	0.0%	2,151,300	6/30/2020
2020 Q1	5/14/2020	7,221	0.0%	2,117,504	3/31/2020
2019 Q4	2/14/2020	9,140	0.0%	1,790,481	12/31/2019
2014 Q1	5/14/2014	17,300	0.0%	1,158,722	3/31/2014
2013 Q4	2/21/2014	17,995	0.0%	1,226,683	12/31/2013